Literature DB >> 26515285

[MR imaging of the prostate].

P Asbach1, M Haas2, B Hamm2.   

Abstract

CLINICAL ISSUE: Prostate cancer is the most common form of cancer in men in Germany; however, there is a distinct difference between incidence and mortality. STANDARD TREATMENT: The detection of prostate cancer is based on clinical and laboratory testing using serum prostate-specific antigen (PSA) levels and transrectal ultrasound with randomized biopsy. DIAGNOSTIC WORK-UP: Multiparametric MR imaging of the prostate can provide valuable diagnostic information for detection of prostate cancer, especially after negative results of a biopsy prior to repeat biopsy. PERFORMANCE: In addition the use of MR ultrasound fusion-guided biopsy has gained in diagnostic importance and has increased the prostate cancer detection rate. ACHIEVEMENTS AND PRACTICAL RECOMMENDATIONS: The prostate imaging reporting and data system (PI-RADS) classification has standardized the reporting of prostate MRI which has positively influenced the acceptance by urologists.

Entities:  

Keywords:  Fusion guided biopsy; Magnetic resonance imaging; Multiparametric imaging; Prostate; Prostate imaging reporting and data system

Mesh:

Year:  2015        PMID: 26515285     DOI: 10.1007/s00117-015-0035-0

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  13 in total

Review 1.  Dynamic contrast-enhanced magnetic resonance imaging and pharmacokinetic models in prostate cancer.

Authors:  Tobias Franiel; Bernd Hamm; Hedvig Hricak
Journal:  Eur Radiol       Date:  2010-12-24       Impact factor: 5.315

2.  Ultra-high b-value diffusion-weighted MRI for the detection of prostate cancer with 3-T MRI.

Authors:  Yoshiko Ueno; Kazuhiro Kitajima; Kazuro Sugimura; Fumi Kawakami; Hideaki Miyake; Makoto Obara; Satoru Takahashi
Journal:  J Magn Reson Imaging       Date:  2013-01-04       Impact factor: 4.813

3.  Accuracy of multiparametric MRI for prostate cancer detection: a meta-analysis.

Authors:  Maarten de Rooij; Esther H J Hamoen; Jurgen J Fütterer; Jelle O Barentsz; Maroeska M Rovers
Journal:  AJR Am J Roentgenol       Date:  2014-02       Impact factor: 3.959

4.  Location of Prostate Cancers Determined by Multiparametric and MRI-Guided Biopsy in Patients With Elevated Prostate-Specific Antigen Level and at Least One Negative Transrectal Ultrasound-Guided Biopsy.

Authors:  Martijn G Schouten; Caroline M A Hoeks; Joyce G R Bomers; Christina A Hulsbergen-van de Kaa; J Alfred Witjes; Les C Thompson; Maroeska M Rovers; Jelle O Barentsz; Jurgen J Fütterer
Journal:  AJR Am J Roentgenol       Date:  2015-07       Impact factor: 3.959

5.  Prostate Cancer: Interobserver Agreement and Accuracy with the Revised Prostate Imaging Reporting and Data System at Multiparametric MR Imaging.

Authors:  Berrend G Muller; Joanna H Shih; Sandeep Sankineni; Jamie Marko; Soroush Rais-Bahrami; Arvin Koruthu George; Jean J M C H de la Rosette; Maria J Merino; Bradford J Wood; Peter Pinto; Peter L Choyke; Baris Turkbey
Journal:  Radiology       Date:  2015-06-18       Impact factor: 11.105

6.  The value of ADC, T2 signal intensity, and a combination of both parameters to assess Gleason score and primary Gleason grades in patients with known prostate cancer.

Authors:  Johannes Nowak; Uwe Malzahn; Alexander D J Baur; Uta Reichelt; Tobias Franiel; Bernd Hamm; Tahir Durmus
Journal:  Acta Radiol       Date:  2014-12-12       Impact factor: 1.990

7.  MR imaging of the prostate and adjacent anatomic structures before, during, and after ejaculation: qualitative and quantitative evaluation.

Authors:  Milica Medved; Steffen Sammet; Ambereen Yousuf; Aytekin Oto
Journal:  Radiology       Date:  2014-02-01       Impact factor: 11.105

8.  Evaluation of the prostate imaging reporting and data system for the detection of prostate cancer by the results of targeted biopsy of the prostate.

Authors:  Alexander D J Baur; Andreas Maxeiner; Tobias Franiel; Ergin Kilic; Alexander Huppertz; Carsten Schwenke; Bernd Hamm; Tahir Durmus
Journal:  Invest Radiol       Date:  2014-06       Impact factor: 6.016

9.  Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies.

Authors:  Morgan R Pokorny; Maarten de Rooij; Earl Duncan; Fritz H Schröder; Robert Parkinson; Jelle O Barentsz; Leslie C Thompson
Journal:  Eur Urol       Date:  2014-03-14       Impact factor: 20.096

10.  ESUR prostate MR guidelines 2012.

Authors:  Jelle O Barentsz; Jonathan Richenberg; Richard Clements; Peter Choyke; Sadhna Verma; Geert Villeirs; Olivier Rouviere; Vibeke Logager; Jurgen J Fütterer
Journal:  Eur Radiol       Date:  2012-02-10       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.